Skip to main content
Caplight Logo









Radar Healthcare

Radar Healthcare

Private
LeedsHealthcare & Life Scienceshttps://radarhealthcare.com/

Last Round

Buyout/LBO

Nov 8, 2024

Total Funding Raised

$2.61M

Company Overview

Radar Healthcare is a healthtech company that provides a risk, quality, and compliance management software platform for healthcare and social care organizations.

Sector

Healthcare & Life Sciences

Verticals

Compliance & Risk, Quality Management, Vertical SaaS, Incident Response, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS

AI Layer

Application

Keywords

healthcare complianceincident managementrisk management softwarequality managementhealthcare SaaSGRC softwaregovernance, risk, and complianceclinical auditpatient safety softwareworkforce complianceregulatory reportinghealthcare analyticshealthtechNHS softwarecompliance automation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Radar Healthcare Comparables

Compare Radar Healthcare with similar companies based on industry and business-model similarity.

Radar Healthcare comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
RLDatix
86%
Ulysses (2000) Ltd
82%
Vantage Technologies Limited
81%

Radar Healthcare Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Buyout/LBONov 8, 2024
GrantApr 5, 2023
VC RoundJun 16, 2022
SeedOct 23, 2017
SeedApr 7, 2014

Radar Healthcare Investors

Notable investors and investment history

Radar Healthcare investors
InvestorRounds
Marlin Equity PartnersBuyout/LBO
Innovate UKGrant
Mercia Asset ManagementSeed
Finance YorkshireSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 8, 2024

    Led by Marlin Equity Partners.

  • Apr 5, 2023

    Received grant funding from Innovate UK.

Radar Healthcare Filings

Explore SEC and related filing metadata, where available.

Radar Healthcare filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Radar Healthcare's valuation, stock price, and market status.

Is Radar Healthcare a public or private company?

Radar Healthcare is a private company.

What is the current stock price of Radar Healthcare?

Radar Healthcare is a private company with no public stock price. No recent secondary market data is available.

How much is Radar Healthcare worth (valuation)?

Valuation information for Radar Healthcare is not publicly available.

Can I buy Radar Healthcare stock?

Radar Healthcare shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Radar Healthcare's last funding round?

Radar Healthcare's most recent funding round was Buyout/LBO on November 8, 2024.

Who are the main investors in Radar Healthcare?

Key investors in Radar Healthcare include Marlin Equity Partners, Innovate UK, Finance Yorkshire.

Will Radar Healthcare IPO soon?

No public IPO plans have been announced for Radar Healthcare.

How can I track Radar Healthcare secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Radar Healthcare's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLeeds
Year Founded2012
Last FundingNov 8, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?